Autogenous Rib Grafts for Reconstruction of Sternal Defects after Partial Resection: a New Surgical Technique.
Ying Chai,Guofei Zhang,Gang Shen
DOI: https://doi.org/10.1097/prs.0b013e31816b12d2
2008-01-01
Plastic & Reconstructive Surgery
Abstract:Sir: Patients who have undergone sternum resection due to infection, tumor, or trauma need grafts to stabilize the sternum. The requirements of an ideal replacement for reconstruction of the sternum are availability, durability, nonreactivity, and resistance to infection.1,2 In this communication, we describe our use of autogenous rib grafts to reconstruct the middle segment defect of the sternum in three patients who had undergone partial resection. From March of 2000 to December of 2005, three patients with lesions in the middle segment of the sternum presented to our medical center. Their data are listed in Table 1. Chest computed tomographic scans taken at hospital admission revealed expansile lesions and the presence of osteolytic lesions in the sternum, with no apparent involvement of the mediastinal structures. No other abnormities were found during further examination, so surgical treatment was scheduled.Table 1: Patient DataA longitudinal 10-cm skin incision was made over the middle portion of the sternum. Dissection was performed laterally onto the costal cartilages. After being divided transversely at the lower and upper edges of the sternal lesions by fret-saw, the tumor was removed from the sternum, which resulted in a vertical defect of 4.0 to 5.0 cm. Normal margins were obtained in the operating room. Through a left anterior lateral incision, rib grafts that had double the vertical dimensions of the sternal defects were obtained from the seventh or eighth rib after it was stripped of its periosteum and divided into two parts. Slots were cut into the two edges of the sternum in the host site and the ends of the two rib grafts using an electric drill. The two rib grafts were then placed parallel to one another, arranged between the edges of the residual sternum, and connected to the sternum with sternal wires (Fig. 1). The donor-site pleura was not ruptured during the operation in any of our three patients. A drainage tube was placed below the transplanted ribs to drain the effusion and avoid infection after the grafting procedure. Parts of the pectoralis major muscles were then mobilized and reapproximated in the midline over the grafts. Finally, the remaining rib periosteum in the donor site was closed to tube-form, and muscles and skin were closed in layers.Fig. 1.: The two parallel rib grafts were arranged between the edges of the residual sternum and connected to them with sternal wires.Postoperative recovery went well and there were no complications, such as respiratory trouble, infection, or instability of the sternum. Three months postoperatively, computed tomographic scans of the reconstructed chest showed neither dislocation nor abnormality of the transplanted ribs, which connected well to the sternum; new ribs in the donor site had also regenerated (Fig. 2).Fig. 2.: Computed tomographic scan of the reconstructed chest 3 months postoperatively.Autogenous rib grafts, which have proved to be very suitable for reconstruction in maxillofacial surgery, have many advantages, such as biocompatibility, stabilization, strength, and lack of risk of disease associated with prosthetic materials and myoplasties.3,4 Moreover, they are easy to obtain and have lower economic costs for patients compared with prosthetic materials. In our practice, the autogenous rib grafts were successfully used to reconstruct sternal defects after partial resection. This method was found to be effective and sufficient to prevent infection and rejection and to provide stabilization. We consider transfer of autogenous rib grafts to bridge a partial defect in the sternum to be a simple and satisfactory solution to a complex problem. Ying Chai, M.D. Guofei Zhang, M.D. Gang Shen, M.D. Department of Thoracic Surgery Second Affiliated Hospital College of Medicine Zhejiang University Hangzhou, China DISCLOSURES The communication submitted does not contain any information about medical devices and drugs. No financial support or benefits have been received by the senior author or any coauthor, by any member of their immediate family, or by any individual or entity with whom or with which they have a significant relationship from any commercial source that is related directly or indirectly to the scientific work that is reported on in the communication.